Ichon, Moureen C.
HRN: 28-12-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFUROXIME 500MG (TAB)
12/06/2025
12/13/2025
PO
1 Tab
BID
S/P NSVD
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines